<DOC>
	<DOCNO>NCT00374712</DOCNO>
	<brief_summary>Patients chronic kidney disease ( CKD ) end-stage renal disease ( ESRD ) undergo renal replacement therapy show elevated serum phosphate level predispose cardiovascular calcification high risk death cardiovascular disease . However , certain patient hyperphosphatemia relate dialysis insufficiency , excessive daily dietary phosphorus intake high serum parathyroid hormone ( PTH ) level , suggest mechanism could involve . Transgenic mouse lack klotho gene show phenotype resembles dialyze ESRD patient , sense hyperphosphatemia , vascular calcification , short lifespan . This study analyze whether functional polymorphism variant human klotho gene associate hyperphosphatemia patient .</brief_summary>
	<brief_title>Klotho Gene Polymorphism Dialyzed Patients With Hyperphosphatemia</brief_title>
	<detailed_description>The entire coding region klotho gene sequence look functional variant polymorphisms differentiate two group adult dialyze ESRD patient , match age gender , comparable value dialysis dose daily protein intake . These two group consist one group 20 adult , dialyzed patient serum phosphate level &gt; 2.50 mM compare another group 20 adult , dialyze ESRD patient serum phosphate level &lt; 1.50 mM . The result study allow determine whether relationship extreme hyperphosphatemia klotho gene polymorphism dialyse ESRD patient .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Hyperphosphatemia</mesh_term>
	<mesh_term>Renal Osteodystrophy</mesh_term>
	<criteria>Group 1 Stable hemodialysis patient least 3 month Phosphatemia &gt; 2.5 mM Kt/V &gt; 1.2 Total weekly phosphate removal &gt; 75 millimoles Group 2 Stable hemodialysis patient least 3 month Phosphatemia &lt; 1.5 mM Kt/V &gt; 1.2 Total weekly phosphate removal &gt; 25 millimoles Age &gt; 80 year Insufficient dialysis dose ( Kt/V &lt; 1.2 ) Total weekly phosphate removal &lt; 25 mM Problems vascular access hemodialysis ( central catheter , arteriovenous [ AV ] fistula dysfunction ) Methods dialysis different classical hemodialysis ( peritoneal , hemofiltration , hemodiafiltration without acetate ) Intolerance allergy ARYLANE M9 dialyzer Hypocalcemia &lt; 2.0 mmol/liter Hypophosphatemia &lt; 0.6 mmol/liter Daily protein intake &lt; 0.6 g/kg/j Parathyroidectomy least 3 month prior study Evolutive neoplasia without secondary lytic bone lesion Intestinal malabsorption Alcoholism Corticotherapy Treatment bisphosphonates , fluor recombinant PTH Malnutrition ( body mass index [ BMI ] &lt; 15 ) Amputation low member ( &gt; 10 % total body ) Prolonged immobilization Secondary hyperparathyroidism ( PTH &gt; 1400 pg/ml ) Vitamin D deficiency ( 25OHD3 &lt; 10 ng/ml )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Phosphate</keyword>
	<keyword>Dialysis</keyword>
	<keyword>Klotho</keyword>
	<keyword>Hemodialysis</keyword>
</DOC>